The Selective Cyclooxygenase-2-Inhibitor Rofecoxib may Improve the Treatment of Chronic Idiopathic Urticaria

Boehncke, W.-H. and Ludwig, R.J. and Zollner, T.M. and Ochsendorf, F. and Kaufmann, R. and Gibbs, Bernhard F (2003) The Selective Cyclooxygenase-2-Inhibitor Rofecoxib may Improve the Treatment of Chronic Idiopathic Urticaria. British Journal of Dermatology, 148 (3). pp. 604-606. ISSN 0007-0963. (The full text of this publication is not available from this repository)

The full text of this publication is not available from this repository. (Contact us about this Publication)
Official URL
http://dx.doi.org/10.1046/j.1365-2133.2003.05209_1...
Item Type: Article
Subjects: R Medicine
Q Science > QR Microbiology > QR180 Immunology
Divisions: Faculties > Science Technology and Medical Studies > Medway School of Pharmacy
Depositing User: Bernhard F. Gibbs
Date Deposited: 05 Sep 2008 12:40
Last Modified: 20 May 2014 15:09
Resource URI: http://kar.kent.ac.uk/id/eprint/4812 (The current URI for this page, for reference purposes)
  • Depositors only (login required):